CYRAMZA CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML
Product details
Registration number: SIN15035P
Classification: Prescription Only
Active ingredients: Ramucirumab
Strength: 10mg/ml
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Route: INTRAVENOUS
Registrant: DKSH SINGAPORE PTE. LTD.
ATC code: L01XC21
HSA approval date: 21 June 2016
Manufacturer(s):
- Eli Lilly and Company
- LILY FRANCE-FEGERSHEIM
Manufacturing country/countries: UNITED STATES; FRANCE
What are the HSA registration number and classification for CYRAMZA CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15035P
Classification: Prescription Only
What active ingredients and strength are recorded for CYRAMZA CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Ramucirumab
Strength: 10mg/ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for CYRAMZA CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Route: INTRAVENOUS
Who is the recorded registrant for CYRAMZA CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML?
According to the HSA dataset updated 7 August 2026:
Registrant: DKSH SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for CYRAMZA CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Eli Lilly and Company
- LILY FRANCE-FEGERSHEIM
Manufacturing country/countries: UNITED STATES; FRANCE
Where can I look up CYRAMZA CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15035P or the exact product name CYRAMZA CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML. The general register link does not preselect this product.
What are the source dates for this CYRAMZA CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this CYRAMZA CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15035P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)